| Literature DB >> 32153536 |
Hongchao Wang1,2, Chen Zhang1,2, Haiqin Chen1,2, Zhennan Gu1,2, Jianxin Zhao1,2, Hao Zhang1,2,3, Yong Q Chen1,2,3, Wei Chen1,2,3.
Abstract
Tetrahydrobiopterin (BH4) is well-known as a cofactor of phenylalanine hydroxylase (PAH) and nitric oxide synthase (NOS), but its exact role in lipogenesis is unclear. In this study, the GTP cyclohydrolase I (GTPCH) gene was overexpressed to investigate the role of BH4 in lipogenesis in oleaginous fungus Mortierella alpina. Transcriptome data analysis reveal that GTPCH expression was upregulated when nitrogen was exhausted, resulting in lipid accumulation. Significant changes were also found in the fatty acid profile of M. alpina grown on medium that contained a GTPCH inhibitor relative to that of M. alpina grown on medium that lacked the inhibitor. GTPCH overexpression in M. alpina (the MA-GTPCH strain) led to a sevenfold increase in BH4 levels and enhanced cell fatty acid synthesis and poly-unsaturation. Increased levels of nicotinamide adenine dinucleotide phosphate (NADPH) and upregulated expression of NADPH-producing genes in response to enhanced BH4 levels were also observed, which indicate a novel aspect of the NADPH regulatory mechanism. Increased BH4 levels also enhanced phenylalanine hydroxylation and nitric oxide synthesis, and the addition of an NOS or a PAH inhibitor in the MA-GTPCH and control strain cultures decreased fatty acid accumulation, NADPH production, and the transcript levels of NADPH-producing genes. Our research suggests an important role of BH4 in lipogenesis and that the phenylalanine catabolism and arginine-nitric oxide pathways play an integrating role in translating the effects of BH4 on lipogenesis by regulating the cellular NADPH pool. Thus, our findings provide novel insights into the mechanisms of efficient lipid biosynthesis regulation in oleaginous microorganisms and lay a foundation for the genetic engineering of these organisms to optimize their dietary fat yield.Entities:
Keywords: GTP cyclohydrolase I; Mortierella alpine; NADPH; lipogenesis; tetrahydrobiopterin
Year: 2020 PMID: 32153536 PMCID: PMC7044132 DOI: 10.3389/fmicb.2020.00250
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Fatty acid content in different M. alpina strains.
| Control | DAHP | CP | |||||
| TFA/biomass (%, wt/wt) | 30.07% | 18.96% | 41.24% | 14.94% | 24.07% | 22.52% | 24.95% |
| C16:0/biomass (%, wt/wt) | 4.45% | 3.34% | 5.64% | 2.88% | 3.25% | 5.21% | 3.92% |
| C18:0/biomass (%, wt/wt) | 3.36% | 1.82% | 5.16% | 1.20% | 3.19% | 2.10% | 3.55% |
| C18:1/biomass (%, wt/wt) | 5.88% | 5.73% | 4.80% | 6.14% | 7.34% | 6.65% | 6.63% |
| C18:2/biomass (%, wt/wt) | 2.09% | 1.23% | 3.00% | 0.89% | 1.66% | 1.72% | 1.75% |
| C18:3/biomass (%, wt/wt) | 1.42% | 0.93% | 1.55% | 0.59% | 0.94% | 1.34% | 1.35% |
| C20:3/biomass (%, wt/wt) | 1.26% | 0.57% | 1.44% | 0.25% | 1.13% | 0.62% | 0.87% |
| C20:4/biomass (%, wt/wt) | 9.81% | 4.24% | 17.50% | 2.50% | 5.60% | 4.08% | 6.23% |
| Biomass (g/L) | 11.82 | 11.91 | 11.73 | 11.65 | 11.77 | 11.69 | 11.95 |
FIGURE 1Roles of GTPCH in fatty acid biosynthesis. Transcript abundance of the GTPCH gene during lipid accumulation in wild-type M. alpina (A) (Chen et al., 2015). FPKM, Fragments per kilobase of exon per million fragments mapped. Effects of a GTPCH inhibitor and GTPCH overexpression on the fatty acid content in M. alpina after 8 days of cultivation (B). Effects of GTPCH overexpression on the relative transcript levels of GTPCH in M. alpina after 8 days of cultivation (C). Control, pBIG2-ura5s-IT1-containing M. alpina CCFM 501 strain grown on inhibitor-free medium, defined as 100%. TFA (total fatty acids); C16:0 (palmitic acid); C18:0 (stearic acid); C18:1 (oleic acid); C18:2 (linoleic acid); C18:3 (γ-linolenic acid); C20:3 (dihomo-γ-linolenic acid); C20:4 (arachidonic acid). The data shown are the averages (±standard deviations) of three independent experiments.
FIGURE 2Biopterin (A) and folate (B) contents in GTPCH-overexpressing M. alpina strain (MA-GTPCH) and pBIG2-ura5s-IT1-containing M. alpina CCFM 501 strain (control). The data shown are the averages (±standard deviations) of three independent experiments.
FIGURE 3Effects of increased BH4 levels on the NADPH content (A) and transcript levels of NADPH-producing genes involved in glycolysis, PPP, phenylalanine metabolism, TCA cycle, and one carbon pool by folate in M. alpina (B). Control, pBIG2-ura5s-IT1-containing M. alpina CCFM 501 strain. The data shown are the averages (±standard deviations) of three independent experiments.
FIGURE 4Effects of PAH and NOS inhibitors on the relative contents of NADPH and fatty acids, and relative transcript levels of NADPH-producing genes involved in glycolysis, PPP, TCA cycle, and one carbon pool by folate in the GTPCH-overexpressing M. alpina strain (MA-GTPCH) and the pBIG2-ura5s-IT1-containing M. alpina CCFM 501 strain (control). CP (4-chloro-DL-phenylalanine); L-NAME (N-nitro-L-arginine methyl ester). The data shown are the averages of three independent experiments.
FIGURE 5NADPH regulation in glycolysis, PPP, TCA cycle, and one carbon pool by folate. The upward arrows indicate increased levels of BH4, NO, and tyrosine and upregulation of transcript levels in the GTPCH-overexpressing M. alpina strain (MA-GTPCH).